286 related articles for article (PubMed ID: 1702555)
1. Long-term human B cell lines dependent on interleukin-4 and antibody to CD40.
Banchereau J; de Paoli P; Vallé A; Garcia E; Rousset F
Science; 1991 Jan; 251(4989):70-2. PubMed ID: 1702555
[TBL] [Abstract][Full Text] [Related]
2. Responsiveness of chronic lymphocytic leukemia B cells activated via surface Igs or CD40 to B-cell tropic factors.
Fluckiger AC; Rossi JF; Bussel A; Bryon P; Banchereau J; Defrance T
Blood; 1992 Dec; 80(12):3173-81. PubMed ID: 1281692
[TBL] [Abstract][Full Text] [Related]
3. Cytokine-induced proliferation and immunoglobulin production of human B lymphocytes triggered through their CD40 antigen.
Rousset F; Garcia E; Banchereau J
J Exp Med; 1991 Mar; 173(3):705-10. PubMed ID: 1705282
[TBL] [Abstract][Full Text] [Related]
4. Engagement of CD40 lowers the threshold for activation of resting B cells via antigen receptor.
Wheeler K; Pound JD; Gordon J; Jefferis R
Eur J Immunol; 1993 May; 23(5):1165-8. PubMed ID: 7682959
[TBL] [Abstract][Full Text] [Related]
5. Anti-immunoglobulin and anti-CD40 stimulation induces CD25 expression by resting human tonsillar B lymphocytes.
Burlinson EL; Pringle HM; Ozanne BW; Cushley W
Immunol Lett; 1995 Feb; 45(1-2):93-8. PubMed ID: 7542628
[TBL] [Abstract][Full Text] [Related]
6. Role of cytokines in human B lymphocyte growth and differentiation.
Banchereau J; Blanchard D; Brière F; Galizzi JP; Garrone P; Hermann P; Lebecque S; Rousset F
Nouv Rev Fr Hematol (1978); 1993 Feb; 35(1):61-6. PubMed ID: 7685519
[TBL] [Abstract][Full Text] [Related]
7. Soluble forms of CD40 inhibit biologic responses of human B cells.
Fanslow WC; Anderson DM; Grabstein KH; Clark EA; Cosman D; Armitage RJ
J Immunol; 1992 Jul; 149(2):655-60. PubMed ID: 1378075
[TBL] [Abstract][Full Text] [Related]
8. CD40 signaling pathway: anti-CD40 monoclonal antibody induces rapid dephosphorylation and phosphorylation of tyrosine-phosphorylated proteins including protein tyrosine kinase Lyn, Fyn, and Syk and the appearance of a 28-kD tyrosine phosphorylated protein.
Faris M; Gaskin F; Parsons JT; Fu SM
J Exp Med; 1994 Jun; 179(6):1923-31. PubMed ID: 7515102
[TBL] [Abstract][Full Text] [Related]
9. Molecular interactions mediating T-B lymphocyte collaboration in human lymphoid follicles. Roles of T cell-B-cell-activating molecule (5c8 antigen) and CD40 in contact-dependent help.
Lederman S; Yellin MJ; Inghirami G; Lee JJ; Knowles DM; Chess L
J Immunol; 1992 Dec; 149(12):3817-26. PubMed ID: 1281189
[TBL] [Abstract][Full Text] [Related]
10. Interleukin 10 and transforming growth factor beta cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A.
Defrance T; Vanbervliet B; Brière F; Durand I; Rousset F; Banchereau J
J Exp Med; 1992 Mar; 175(3):671-82. PubMed ID: 1371300
[TBL] [Abstract][Full Text] [Related]
11. Anti-CD40 monoclonal antibodies or CD4+ T cell clones and IL-4 induce IgG4 and IgE switching in purified human B cells via different signaling pathways.
Gascan H; Gauchat JF; Aversa G; Van Vlasselaer P; de Vries JE
J Immunol; 1991 Jul; 147(1):8-13. PubMed ID: 1711085
[TBL] [Abstract][Full Text] [Related]
12. Growing human B lymphocytes in the CD40 system.
Banchereau J; Rousset F
Nature; 1991 Oct; 353(6345):678-9. PubMed ID: 1717852
[TBL] [Abstract][Full Text] [Related]
13. CD20 monoclonal antibodies stimulate extracellular cleavage of the low affinity receptor for IgE (Fc epsilon RII/CD23) in Epstein-Barr-transformed B cells.
Bourget I; Di Berardino W; Breittmayer JP; Grenier-Brossette N; Plana-Prades M; Bonnefoy JY; Cousin JL
J Biol Chem; 1994 Mar; 269(9):6927-30. PubMed ID: 7509812
[TBL] [Abstract][Full Text] [Related]
14. Induction of latent membrane protein expression in in vitro Epstein-Barr virus-infected leukaemic B lymphocytes by interleukin 4 and antibodies to CD40.
Crawford DH; Thomas JA; Gregory CD; Catovsky D; Chaggar K
Leukemia; 1995 May; 9(5):747-53. PubMed ID: 7539512
[TBL] [Abstract][Full Text] [Related]
15. Regulation of resting and cycling human B lymphocytes via surface IgM and the accessory molecules interleukin-4, CD23 and CD40.
Gordon J; Millsum MJ; Flores-Romo L; Gillis S
Immunology; 1989 Dec; 68(4):526-31. PubMed ID: 2481643
[TBL] [Abstract][Full Text] [Related]
16. CD40 and IgE: synergism between anti-CD40 monoclonal antibody and interleukin 4 in the induction of IgE synthesis by highly purified human B cells.
Jabara HH; Fu SM; Geha RS; Vercelli D
J Exp Med; 1990 Dec; 172(6):1861-4. PubMed ID: 1701824
[TBL] [Abstract][Full Text] [Related]
17. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes.
Rousset F; Garcia E; Defrance T; Péronne C; Vezzio N; Hsu DH; Kastelein R; Moore KW; Banchereau J
Proc Natl Acad Sci U S A; 1992 Mar; 89(5):1890-3. PubMed ID: 1371884
[TBL] [Abstract][Full Text] [Related]
18. Hypercross-linking surface IgM or IgD receptors on mature B cells induces apoptosis that is reversed by costimulation with IL-4 and anti-CD40.
Parry SL; Hasbold J; Holman M; Klaus GG
J Immunol; 1994 Mar; 152(6):2821-9. PubMed ID: 7511629
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of B lymphocytes via CD72 (human Lyb-2).
Kamal M; Katira A; Gordon J
Eur J Immunol; 1991 Jun; 21(6):1419-24. PubMed ID: 1828426
[TBL] [Abstract][Full Text] [Related]
20. Fyn tyrosine kinase associated with Fc epsilon RII/CD23: possible multiple roles in lymphocyte activation.
Sugie K; Kawakami T; Maeda Y; Kawabe T; Uchida A; Yodoi J
Proc Natl Acad Sci U S A; 1991 Oct; 88(20):9132-5. PubMed ID: 1717997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
